Similar Posts
Rocket Lab Debuts a Breakthrough Technology Investors Should Have on Their Radar
Rocket Lab (RKLB +4.74%) is building a business that extends well beyond small rocket launches. In its recent Victus Haze mission, Rocket Lab combined an Electron rocket, a company-built Pioneer spacecraft, mission software, ground control systems, and in-space operations into a single rapid response service for the U.S. Space Force. The company launched the spacecraft…
Financial Planning as Employee Benefit Gains Momentum
Brad Arends, CEO and co-founder of Intellicents, has been a long advocate for making financial planning a tax-free employee benefit just like healthcare, dental and 401(k) plans. He’s mostly advocating for personal reasons, believing it’s the right thing to do, and it makes him feel better. “If I were only a Triple F advisor or…
TIER IV joins JST’s Next-Generation Edge AI Semiconductor R&D Program to open-source AI chip designs for autonomous driving
TOKYO, Aug. 14, 2026 /PRNewswire/ — TIER IV, the pioneering force behind open-source software for autonomous driving, has joined the Next-Generation Edge AI Semiconductor Research and Development Program led by the Japan Science and Technology Agency (JST) to advance research and development of a software-defined system-on-chip (SoC) for Level 4 autonomous driving. Under the JST…
Canada and the US discussing tariff relief deal
The Globe & Mail is out with a somewhat optimistic report on the Canadian trade situation and, in turn, the Canadian dollar. It highlights trade negotiations that are currently ongoing between the US and Canada, and appear to be in the final stretch. It says: Canada would address a long list of US trade irritants…
FUEL FALD Study Published in Pediatric Cardiology
Peer-reviewed publication advances understanding of Fontan-associated liver disease (FALD) and adds to the growing body of evidence supporting udenafil in Fontan circulation FORT LEE, N.J., July 16, 2026 /PRNewswire/ — Mezzion Pharmaceuticals today announced publication of “The FUEL FALD Study: Effects of Udenafil on Liver Stiffness and Fibrosis after Fontan” in the peer-reviewed journal Pediatric…
PulteGroup closings, earnings fall, still beat expectations
PulteGroup saw earnings fall again in the second quarter, reflecting a housing market constrained by high mortgage rates and affordability issues. Processing Content The homebuilder posted net income of $472 million, or $2.48 per share, down from $608 million, or $3.03 per share, in the second quarter of last year but still more than analysts…